The medication itself, its viscosity and volume, does not meaningfully affect sensation
Cipla derives around 20 per cent of its total revenue from the US and remains immune from to potential disruptions, given its strong local manufacturing presence in the country
Laminitis can return after recovery, particularly when underlying metabolic conditions remain present
If you suspect degradation, replacing the medication is the safest path forward
Monoclonal antibodies (mAbs), as natural immune molecules, exhibit greater specificity and stability compared to traditional small molecule drugs (79)
But if the product instructions say to apply it during a specific time, or at different times throughout the day, its best to follow the manufacturers directions